Skip to main content

Table 1 (a) and (b): Measurements of zone of inhibitions of the mutants and uncured isolates against each antibiotic

From: Transcriptional expression of secondary resistance genes ccdB and repA2 is enhanced in presence of cephalosporin and carbapenem in Escherichia coli

(a)
Sl. No Antibiotic Uncured isolate (mm) Δ blaNDM Δ blaNDM ΔrepA2 (mm) Δ blaNDM ΔccdB ΔrepA2 (mm)
1 Meropenem 0 12 12 21
2 Imipenem 16 19 19 25
3 Ertapenem 0 13 13 27
4 Ampicillin 0 0 0 0
5 Ceftazidime 0 0 0 25
6 Amikacin 21 30 30 26
7 Gentamicin 25 24 24 22
8 Ciprofloxacin 0 0 0 32
9 Cefepime 0 0 0 26.5
(b)
Sl. No Antibiotic Uncured isolate (mm) Δ blaCTX-M-15 (mm) Δ blaCTX-M-15 ΔccdB (mm) Δ blaCTX-M-15 ΔrepA2 (mm) Δ blaCTX-M-15 ΔccdB ΔrepA2 (mm)
1 Ciprofloxacin 0 0 5 5 32
2 Gentamicin 22 23 29 30 24
3 Imipenem 18 20 23 21 25
4 Meropenem 18 20 23 20 26
5 Amikacin 20 26 30 30 28
6 Ertapenem 17 20 23 22 25
7 Ampicillin 0 5 8 8 16
8 Ceftazidime 10 13 18 18 25
9 Cefepime 0 8 13 13 26